Compass Pathways is leading the charge for psychedelic therapy. The research is currently in stage three trials and is expected to receive FDA approval in the next few years. An expert explains how the treatment works and if the therapy will be covered by insurance.
Learn More: [ Ссылка ]
Learn more about your ad choices. Visit podcastchoices.com/adchoices

свернуть